Lombard Odier Asset Management Switzerland SA Makes New Investment in Mettler-Toledo International, Inc. $MTD

Lombard Odier Asset Management Switzerland SA acquired a new stake in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 781 shares of the medical instruments supplier’s stock, valued at approximately $985,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Geneos Wealth Management Inc. increased its position in shares of Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares in the last quarter. Baird Financial Group Inc. increased its position in Mettler-Toledo International by 3.1% during the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC raised its position in shares of Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after buying an additional 125 shares during the period. Cerity Partners LLC raised its position in Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after purchasing an additional 392 shares during the period. Finally, AXA S.A. lifted its stake in shares of Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after purchasing an additional 131 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Up 0.6%

Shares of MTD opened at $1,335.70 on Tuesday. The firm has a market capitalization of $26.99 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.77 and a beta of 1.24. The firm’s fifty day simple moving average is $1,212.30 and its 200-day simple moving average is $1,276.84. Mettler-Toledo International, Inc. has a twelve month low of $1,023.05 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating the consensus estimate of $8.70 by $0.21. The firm had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.Mettler-Toledo International’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, analysts predict that Mettler-Toledo International, Inc. will post 46.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on MTD shares. JPMorgan Chase & Co. reduced their price target on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Citigroup cut their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Morgan Stanley lowered their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Robert W. Baird cut their price objective on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Finally, Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $1,408.55.

View Our Latest Research Report on MTD

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Read More

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.